Free Trial

Thermo Fisher Scientific (TMO) Stock Price, News & Analysis

Thermo Fisher Scientific logo
$435.02 +4.29 (+1.00%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$432.73 -2.29 (-0.53%)
As of 07/11/2025 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Thermo Fisher Scientific Stock (NYSE:TMO)

Key Stats

Today's Range
$425.65
$436.32
50-Day Range
$390.17
$435.02
52-Week Range
$385.46
$627.88
Volume
2.51 million shs
Average Volume
2.00 million shs
Market Capitalization
$164.22 billion
P/E Ratio
25.51
Dividend Yield
0.40%
Price Target
$600.30
Consensus Rating
Moderate Buy

Company Overview

Thermo Fisher Scientific Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
100th Percentile Overall Score

TMO MarketRank™: 

Thermo Fisher Scientific scored higher than 100% of companies evaluated by MarketBeat, and ranked 7th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Thermo Fisher Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 16 buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Thermo Fisher Scientific has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Thermo Fisher Scientific's stock forecast and price target.
  • Earnings Growth

    Earnings for Thermo Fisher Scientific are expected to grow by 9.79% in the coming year, from $23.28 to $25.56 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Thermo Fisher Scientific is 25.51, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.84.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Thermo Fisher Scientific is 25.51, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.18.

  • Price to Earnings Growth Ratio

    Thermo Fisher Scientific has a PEG Ratio of 2.29. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Thermo Fisher Scientific has a P/B Ratio of 3.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Thermo Fisher Scientific's valuation and earnings.
  • Percentage of Shares Shorted

    1.17% of the float of Thermo Fisher Scientific has been sold short.
  • Short Interest Ratio / Days to Cover

    Thermo Fisher Scientific has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Thermo Fisher Scientific has recently decreased by 10.18%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Thermo Fisher Scientific has a dividend yield of 0.40%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Thermo Fisher Scientific has been increasing its dividend for 8 years.

  • Dividend Coverage

    The dividend payout ratio of Thermo Fisher Scientific is 10.09%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Thermo Fisher Scientific will have a dividend payout ratio of 6.73% next year. This indicates that Thermo Fisher Scientific will be able to sustain or increase its dividend.

  • Read more about Thermo Fisher Scientific's dividend.
  • Percentage of Shares Shorted

    1.17% of the float of Thermo Fisher Scientific has been sold short.
  • Short Interest Ratio / Days to Cover

    Thermo Fisher Scientific has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Thermo Fisher Scientific has recently decreased by 10.18%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Thermo Fisher Scientific has a news sentiment score of 1.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 68 news articles for Thermo Fisher Scientific this week, compared to 36 articles on an average week.
  • Search Interest

    41 people have searched for TMO on MarketBeat in the last 30 days. This is an increase of 21% compared to the previous 30 days.
  • MarketBeat Follows

    Only 7 people have added Thermo Fisher Scientific to their MarketBeat watchlist in the last 30 days. This is a decrease of -30% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Thermo Fisher Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $128,979.00 in company stock.

  • Percentage Held by Insiders

    Only 0.33% of the stock of Thermo Fisher Scientific is held by insiders.

  • Percentage Held by Institutions

    89.23% of the stock of Thermo Fisher Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Thermo Fisher Scientific's insider trading history.
Receive TMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Thermo Fisher Scientific and its competitors with MarketBeat's FREE daily newsletter.

TMO Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Zacks Research Issues Optimistic Forecast for TMO Earnings
UBS Downgrades Thermo Fisher Scientific (TMO)
See More Headlines

TMO Stock Analysis - Frequently Asked Questions

Thermo Fisher Scientific's stock was trading at $520.23 on January 1st, 2025. Since then, TMO stock has decreased by 16.4% and is now trading at $435.02.

Thermo Fisher Scientific Inc. (NYSE:TMO) released its quarterly earnings results on Wednesday, April, 23rd. The medical research company reported $5.15 earnings per share for the quarter, topping the consensus estimate of $5.10 by $0.05. The company's revenue for the quarter was up .2% on a year-over-year basis.
Read the conference call transcript
.

Thermo Fisher Scientific's board initiated a stock buyback plan on Friday, November 15th 2024, which permits the company to repurchase $4,000,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 2% of its shares through open market purchases. Shares buyback plans are often a sign that the company's leadership believes its shares are undervalued.

The following companies are subsidiaries of Thermo Fisher Scientific: Henogen, Phinotex, Qiagen, Brammer Bio, HighChem, Gatan Inc, IntegenX, and others.

Thermo Fisher Scientific's top institutional shareholders include Swedbank AB (0.45%), Alecta Tjanstepension Omsesidigt (0.19%), Perpetual Ltd (0.11%) and Sarasin & Partners LLP (0.07%). Insiders that own company stock include Marc N Casper, Stephen Williamson, Gianluca Pettiti, Jim P Manzi, Lisa P Britt, Michael A Boxer, Joseph R Holmes and Debora L Spar.
View institutional ownership trends
.

Shares of TMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Thermo Fisher Scientific investors own include BlackRock (BLK), Broadcom (AVGO), UnitedHealth Group (UNH), ServiceNow (NOW), The Goldman Sachs Group (GS), Illinois Tool Works (ITW) and NVIDIA (NVDA).

Company Calendar

Record date for 4/15 Dividend
3/14/2025
Ex-Dividend for 4/15 Dividend
3/14/2025
Dividend Payable
4/15/2025
Last Earnings
4/23/2025
Record date for 7/15 Dividend
6/13/2025
Ex-Dividend for 7/15 Dividend
6/13/2025
Today
7/12/2025
Dividend Payable
7/15/2025
Next Earnings (Estimated)
7/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NYSE:TMO
CIK
97745
Employees
125,000
Year Founded
1956

Price Target and Rating

High Price Target
$686.00
Low Price Target
$450.00
Potential Upside/Downside
+38.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
20 Analysts

Profitability

EPS (Trailing Twelve Months)
$17.05
Trailing P/E Ratio
25.51
Forward P/E Ratio
18.69
P/E Growth
2.29
Net Income
$6.34 billion
Net Margins
15.19%
Pretax Margin
16.48%
Return on Equity
17.15%
Return on Assets
8.47%

Debt

Debt-to-Equity Ratio
0.64
Current Ratio
1.77
Quick Ratio
1.38

Sales & Book Value

Annual Sales
$42.88 billion
Price / Sales
3.83
Cash Flow
$30.34 per share
Price / Cash Flow
14.34
Book Value
$129.54 per share
Price / Book
3.36

Miscellaneous

Outstanding Shares
377,490,000
Free Float
376,248,000
Market Cap
$164.22 billion
Optionable
Optionable
Beta
0.77

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NYSE:TMO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners